The EVEREST study: An international collaboration

NDT Plus

Volumn 3, Issue 1, 2010, Pages 28-36

  Caskey, Fergus J ^a,b   Stel, Vianda S ^c   Elliott, Robert F ^d   Jager, Kitty J ^c   Covic, Adrian ^e   Cusumano, Ana ^f,g   Geue, Claudia ^d   Kramer, Anneke ^c   Stengel, Benedicte ^h,i   MacLeod, Alison M ^d  

^a Richard Bright Renal Unit   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

^e GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^f Sociedad Latinoamericana de Nefrologia e Hipertensión ^*  (Australia)

^g CEMIC   (Argentina)

^h INSERM   (France)

ⁱ UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

dialysis; epidemiology and outcomes; risk factors

Indexed keywords

ARTICLE; DIABETES MELLITUS; DIALYSIS; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HUMAN; KIDNEY FAILURE; LIFE EXPECTANCY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY;

EID: 77951694151     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfp146     Document Type: Article

References (27)

1. Chadban SJ, Briganti EM,Kerr PGet al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol 2003; 14: S131-S138
2. Drey N, Roderick P, Mullee M et al. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis 2003; 42: 677-684
3. Hallan SI, Coresh J, Astor BC et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006; 17: 2275-2284
4. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047
5. U.S. Renal Data System. USRDS 2008 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institute of Diabetes and Digestive and Kidney Diseases, 2008
6. Sekkarie M, Cosma M, Mendelssohn D. Nonreferral and nonacceptance to dialysis by primary care physicians and nephrologists in Canada and the United States. Am J Kidney Dis 2001; 38: 36-41
7. Challah S, Wing AJ, Bauer R et al. Negative selection of patients for dialysis and transplantation in the United Kingdom. Br Med J (Clin Res Ed) 1984; 288: 1119-1122
8. McKenzie JK, Moss AH, Feest TG et al. Dialysis decision making in Canada, the United Kingdom, and the United States. Am J Kidney Dis 1998; 31: 12-18
9. Audit in renal failure; the wrong target? Br Med J (Clin Res Ed) 1981; 283: 261-262
10. De Vecchi AF, Dratwa M, Wiedemann ME. Healthcare systems and end-stage renal disease (ESRD) therapies-an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant 1999; 14: 31-41
11. Grassmann A, Gioberge S, Moeller S et al. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant 2005; 20: 2587-2593
12. HorlWH,deAlvaro F,Williams PF. Healthcare systems and end-stage renal disease (ESRD) therapies-an international review: access to ESRD treatments. Nephrol Dial Transplant 1999; 14(Suppl 6): 10-15
13. MacGregor MS, Agar JWM, Blagg CR. Home haemodialysis-international trends and variation. Nephrol Dial Transplant 2006; 21: 1934-1945
14. Wordsworth S, Ludbrook A, Caskey F et al. Collecting unit cost data in multicentre studies. Creating comparable methods. Eur J Health Econ 2005; 6: 38-44
15. Just PM, de Charro FT, Tschosik EA et al. Reimbursement and economic factors influencing dialysis modality choice around the world. Nephrol Dial Transplant 2008; 23: 2365-2373
16. Finkelstein FO. Structural requirements for a successful chronic peritoneal dialysis program. Kidney Int Suppl 2006; S118-S121
17. Jung B, Blake PG, MehtaRLet al.Attitudes ofCanadian nephrologists toward dialysis modality selection. Perit Dial Int 1999; 19: 263-268
18. Mendelssohn DC, Mullaney SR, Jung B et al. What do American nephologists think about dialysis modality selection? Am J Kidney Dis 2001; 37: 22-29
19. Held PJ, Brunner F, Odaka M et al. Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis 1990; 15: 451-457
20. Marcelli D, Stannard D, Conte F et al. ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int 1996; 50: 1013-1018
21. Young EW, Goodkin DA, Mapes DL et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS): an international hemodialysis study. Kidney Int 2000; 57: S74-S81
22. LameireN,Van Biesen W. The pattern of referral of patients with endstage renal disease to the nephrologist-a European survey. Nephrol Dial Transplant 1999; 14(Suppl 6): 16-23
23. van Dijk PC, Zwinderman AH, Dekker FW et al. Effect of general population mortality on the north-south mortality gradient in patients on replacement therapy in Europe. Kidney Int 2007; 71: 53-59
24. YoshinoM, Kuhlmann MK, Kotanko P et al. International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J AmSoc Nephrol 2006; 17: 3510-3519
25. Dor A, Pauly MV, Eichleay MA et al. End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF). Int J Health Care Finance Econ 2007; 7: 73-111
26. Caskey FJ, Schober-Halstenberg HJ, Roderick PJ et al. Exploring the differences in epidemiology of treated ESRD between Germany and England and Wales. Am J Kidney Dis 2006; 47: 445-454
27. Slade EP, Anderson GF. The relationship between per capita income and diffusion of medical technologies. Health Policy (Amsterdam, Netherlands) 2001; 58: 1-14